VBValter Augusto de Freitas Barbosa

Valter Augusto de Freitas Barbosa

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Valter Augusto de Freitas Barbosa has a total of 15 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Covid-19 rapid test by combining a random forest based web system and blood tests

    by Valter Augusto de Freitas Barbosa, Juliana Carneiro Gomes, Maíra Araújo de Santana, Clarisse Lins de Lima, Raquel Bezerra Calado, Claúdio Roberto Bertoldo Júnior, Jeniffer Emidio de Almeida Albuquerque, Rodrigo Gomes de Souza, Ricardo Juarez Escorel de Araújo, Ricardo Emmanuel de Souza, et al.

    Background: The disease caused by the new type of coronavirus, the Covid-19, has posed major public health challenges for many countries. With its rapid spread, since the beginning of the outbreak in December 2019, the disease transmitted by SARS-Cov2 has already caused over 400 thousand deaths to date. The diagnosis of the disease has an important role in combating Covid-19. Objective: In this work, we propose a web system, Heg.IA, which seeks to optimize the diagnosis of Covid-19 through the use of artificial intelligence. Method: The main ideia is that healthcare professionals can insert 41 hematological parameters from common blood tests and arterial gasometry into the system. Then, Heg.IA will provide a diagnostic report. It will indicate if the patient is infected with SARS-Cov2 virus, and also predict the type of hospitalization (regular ward, semi-ICU, or ICU). Results: We developed a web system called Heg.IA to support decision-making regarding to diagnosis of Covid-19 and to the indication of hospitalization on regular ward, semi-ICU or ICU. This application is based on decision trees in a Random Forest architecture with 90 trees. The system showed to be highly efficient, with great results for both Covid-19 diagnosis and to recommend hospitalization. For the first scenario we found average results of accuracy of 92.891% ± 0.851, kappa index of 0.858 ± 0.017, sensitivity of 0.936 ± 0.011, precision of 0.923 ± 0.011, specificity of 0.921 ± 0.012 and area under ROC of 0.984 ± 0.003. As for the indication of hospitalization, we achieved excellent performance of accuracies above 99% and more than 0.99 for the other metrics in all situations. Conclusion: By using a computationally simple method, based on the classical decision trees, we were able to achieve high diagnosis performance. Heg.IA system may be a way to overcome the testing unavailability in the context of Covid-19. We also expect the system will provide wide access to Covid-19 effective diagnosis and thereby reach and help saving lives.


  • Open Access

    Heg.IA: An intelligent system to support diagnosis of Covid-19 based on blood tests

    by Valter Augusto de Freitas Barbosa, Juliana Carneiro Gomes, Maíra Araújo de Santana, Jeniffer Emidio de Almeida Albuquerque, Rodrigo Gomes de Souza, Ricardo Emmanuel de Souza, Wellington Pinheiro dos Santos

    A new kind of coronavirus, the SARS-Cov2, started the biggest pandemic of the century. It has already killed more than 250,000 people. Because of this, it is necessary quick and precise diagnosis test. The current gold standard is the RT-PCR with DNA sequencing and identification, but its results takes too long to be available. Tests base on IgM/IgG antibodies have been used, but their sensitivity and specificity may be very low. Many studies have been demonstrating the Covid-19 impact in hematological parameters. This work proposes an intelligent system to support Covid-19 diagnosis based on blood testing. We tested several machine learning methods, and we achieved high classification performance: 95.159% ± 0.693 of overall accuracy, kappa index of 0.903 ± 0.014, sensitivity of 0.968 ± 0.007, precision of 0.938 ± 0.010 and specificity of 0.936 ± 0.011. These results were achieved using classical and low computational cost classifiers, with Bayes Network being the best of them. In addition, only 24 blood tests were needed. This points to the possibility of a new rapid test with low cost. The desktop version of the system is fully functional and available for free use.


  • Open Access

    IKONOS: An intelligent tool to support diagnosis of Covid-19 by texture analysis of x-ray images

    by Juliana Carneiro Gomes, Valter Augusto de Freitas Barbosa, Maira A. Santana, Jonathan Bandeira, Mêuser Jorge Silva Valença, Ricardo Emmanuel de Souza, Aras Masood Ismael, Wellington Pinheiro dos Santos

    In late 2019, the SARS-Cov-2 spread worldwide. The virus has high rates of proliferation and causes severe respiratory symptoms, such as pneumonia. There is still no specific treatment and diagnosis for the disease. The standard diagnostic method for pneumonia is chest X-ray image. There are many advantages to using Covid-19 diagnostic X-rays: low cost, fast and widely available. We propose an intelligent system to support diagnosis by X-ray images. We tested Haralick and Zernike moments for feature extraction. Experiments with classic classifiers were done. Support vector machines stood out, reaching an average accuracy of 89.78%, average recall and sensitivity of 0.8979, and average precision and specificity of 0.8985 and 0.9963 respectively. The system is able to differentiate Covid-19 from viral and bacterial pneumonia, with low computational cost.